Intestinal Parasites in Diabetes Mellitus Patients in the Limbe and Buea Municipalities, Cameroon

Authors

  • Fominyam Boris Tangi Faculty of Health Sciences, Department of Medical Laboratory Science, University of Buea, Buea, Cameroon
  • Eric Bertrand Fokam Faculty of Science, Department of Zoology and Animal Physiology, University of Buea, Buea, Cameroon
  • Njunda Anna Longdoh Faculty of Health Sciences, Department of Medical Laboratory Science, University of Buea, Buea, Cameroon
  • Enoh Jude Eteneneng Faculty of Health Sciences, Department of Medical Laboratory Science, University of Buea, Buea, Cameroon

DOI:

https://doi.org/10.17140/DROJ-2-123

Keywords:

Protozoa, Helminthes, Diabetes mellitus, Prevalence

Abstract

Background: Intestinal parasites are an important cause of morbidity and mortality and a public health problem especially in tropical developing countries including Cameroon. The two main types of intestinal parasites are helminths and protozoa which are important causes of infections in immunocompromised individuals. Diabetes Mellitus (DM) is a metabolic non-communicable
disease in which a person has high blood glucose. DM is an increasing problem in our community today and diabetics have been reported to be immunocompromised. The purpose of this study was to determine the prevalence and type of intestinal parasites in DM patients living in Buea and Limbe municipalities. Methods: This hospital based cross sectional study involved a total 150 diabetic patients and 85 non-diabetic individuals which served as control group. Questionnaires were administered to the Diabetic patients only. Fresh stool specimens were collected and processed using Direct Microscopy, Formalin-Ether Concentration, Stoll’s technique and Modified Ziehl Nielsen staining techniques. Data was analyzed using Microsoft Office Excel 2013 and Statistical Package
for Social Sciences (SPSS) version 20. Results: The overall prevalence of intestinal parasites among diabetics was 10%. The parasites
detected in diabetics included Entamoebahistolytica 10(6.7%), Blastocystishominis 4(2.7%) Ascarislumbricoides 1(0.67%), Hookworm 1(0.67%) and Cryptosporidium parvum 1(0.67%). An overall prevalence of 23.5% of intestinal parasites was observed in the control group with detected parasites Entamoebahistolytica 18(21.2%), Ascarislumbricoides 2(2.4%), and Blastocystishominis 1(1.2%). The prevalence in both groups (10% vs. 23.5%, p=0.0052) were statistically significantly different. DM status was significantly associated with the prevalence of intestinal parasites or acquiring intestinal parasitic infection (OR: 0.36 Confidence Interval (CI)
=0.17-0.75; p=0.0051)). Conclusion: The prevalence of intestinal parasites in diabetics is 10%. The most prevalent type of intestinal parasite in diabetics is Entamoebahistolytica which is same with non-diabetics. The more types of intestinal parasites in diabetics and along with the detection of C. parvum indicates a weakened immune system in diabetics. A protective association exists between Diabetes mellitus and Intestinal Parasitic Infections (IPIs). Diabetic patients should be screened routinely for intestinal parasites especially protozoans and treated for their overall well-being.

References

Gil FF, Barros MJ, Macedo NA, et al. Prevalence of intestinal parasitism and associated symptomatology among hemodialysis patients. Rev. Inst. Med. Trop. Sao Paulo. 2013; 55(2): 69-74. doi: 10.1590/S0036-46652013000200001

Nazligul Y, Sabuncu T, Ozbilge H. Is there a predisposition to intestinal parasitosis in diabetic patients? Diabetes Care. 2001; 24: 1503-1504. doi: 10.2337/diacare.24.8.1503-a

Fantry L. Gastrointestinal infections in the immunocompro-mised host. Curr Opin Gastroenterol. 2002; 18: 34-39.

Barsoum RS. Parasitic infections in organ transplantation. Exp Clin Transplant. 2007; 2: 258-267.

WHO. Infectious Diseases Home Page. Intestinal parasites. 2014.

Crook MA. Carbohydrate metabolism. Clinical Chemistry and Metabolic Medicine. 7th ed. Ocala: Edward Arnold Publish-ers; 2006:174-197.

David G, Gardner T, Dolores R. Greenspan’s basic and clini-cal endocrinology. 9th ed. New York: McGraw-Hill Medical; 2011: 200-220.

Akinbo F, Olujobi O, Omoregie R, Egbe C. Intestinal para-sitic infections among diabetes mellitus patients. Biomarkers and Genomic Medicine. 2013; 5: 44-47. doi: 10.1016/j.gmb-hs.2013.05.003

Wild S, Roglic G, Green A. Global prevalence of diabetes: estimates for the year 2000 and projections for the year 2030. J Diabetes Care. 2004; 27: 1047-1053. doi: 10.2337/dia-care.27.5.1047

Bessman AN, Sapico FL. Infections in the diabetic patient: the role of immune dysfunction and pathogen virulence factors. J Diabetes Complications. 1992; 6: 258-262. doi: 10.1016/1056- 8727(92)90062-P

Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mech-anisms involved: relevance to the increased susceptibility of dia-betic patients to specific infections. Diabete Metab. 1992; 18: 187-201.

Prasad CE. Immunodeficiencies in diabetes and mycobacte-rial infections. Int J Diabetes Dev Countries. 1999; 19: 52-55.

Cheesbrough M. District laboratory practice in tropi-cal countries. 2 nd ed updated. Cambridge University Press; 2009:183-191.

Cimerman S, Cimerman B, Lewi DS. Enteric parasites and AIDS. Sao Paulo Med J. 1999; 117: 266-273. doi: 10.1590/ S1516-31801999000600007

Sarfati C, Bourgeois A, Jean M, et al. Prevalence of intestinal parasites including microsporidia in human immunodeficiency virus-infected adults in Cameroon: a cross-sectional study. Am J Trop Med Hyg. 2006; 74(1): 162-164.

Downloads

Published

2016-02-16

How to Cite

Fominyam Boris Tangi, Eric Bertrand Fokam, Njunda Anna Longdoh, & Enoh Jude Eteneneng. (2016). Intestinal Parasites in Diabetes Mellitus Patients in the Limbe and Buea Municipalities, Cameroon. Diabetes Research, 2(1), 1–7. https://doi.org/10.17140/DROJ-2-123